Sector News

Latest News: Life sciences

July 7, 2020
Life sciences

The European Commission (EC) has approved Novartis’ Enerzair Breezhaler (indacaterol acetate, glycopyrronium bromide and mometasone furoate) for uncontrolled asthma. More specifically, the drug has been cleared as a maintenance treatment […]

July 7, 2020
Life sciences

As COVID-19 vaccines near final stages of testing, governments are also racing against each other, busy securing supply for their own countries even before key efficacy data readouts. After signing […]

July 7, 2020
Life sciences

Johnson & Johnson has been on a manufacturing deal spree as it nears human trials for its COVID-19 vaccine hopeful. On the same day it inked a $480 order from […]

July 2, 2020
Life sciences

Meeting global demand for a potential COVID-19 treatment is more than any one company can handle on its own. Acknowledging that reality, Japanese drugmaker Fujifilm has picked partners for its […]

July 2, 2020
Life sciences

In 2019, the top 10 pharmaceutical R&D spenders collectively plowed a whopping $82 billion into their search for new drugs, diagnostics and vaccines, around $4 billion more than the previous year. […]

Subscribe to our Weekly Newsletter

We're easy to reach